Search results
From Robust Response to Rapid Resistance
MedPage Today· 2 days agoThe cancer treatment landscape dramatically changed since the first approval of an immune checkpoint inhibitor (ICI), ipilimumab, a CTLA-4 inhibitor, in...
Isabella Strahan Shares Difficult Cancer Treatment Side Effect
Parade via Yahoo News· 2 days agoStrahan, Michael Strahan Isabella Strahan is still pushing through her ongoing cancer battle, but...
Cancer causer or heartburn healer? Lawyers make closing pitches in first jury trial over Zantac ...
Chicago Sun-Times· 3 days agoA popular heartburn drug with an active ingredient that degrades into a carcinogen so virulent “It’s the ‘Terminator’ of cancer.” Or a safe and effective ...
7 Years Before Diagnosis – Oxford Scientists Discover Key to Early Cancer Detection
SciTechDaily· 1 day agoTwo studies funded by Cancer Research UK and conducted by Oxford Population Health have identified...
Immunotherapy for stomach cancer: Types and effectiveness
Medical News Today· 3 days agoImmunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in...
J&J plans for capped, flexible dosing after four patient deaths in early study of actinium prostate ...
Endpoints News· 2 days agoAn experimental prostate cancer drug developed by Johnson & Johnson that uses a rare radioactive particle called actinium-225 led to three patients seeing ...
AstraZeneca to build $1.5-bln cancer drug plant in Singapore
Reuters· 6 days ago, opens new tab plans to build a $1.5 billion manufacturing facility in Singapore to produce a...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Colorado Springs Gazette· 3 days agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
Investor's Business Daily· 1 day agoGuardant Health stock jumped Friday after a Food and Drug Administration panel recommended the...
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid...
Nature· 2 days agoUpregulated KDM5B was found in PDAC, associated with poor prognosis and recurrence of PDAC patients. Upregulated KDM5B promotes PDAC tumor malignancy, i.e. cancer cells stemness ...